Cipargamin: Phase II data

An open-label, Thai Phase II trial in 21 adults with uncomplicated Plasmodium vivax or P. falciparum malaria, including patients with

Read the full 202 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE